CLSD logo

CLSD
Clearside Biomedical Inc

5,132
Mkt Cap
$4.32M
Volume
224,055.00
52W High
$17.10
52W Low
$0.31
PE Ratio
-0.19
CLSD Fundamentals
Price
$0.95
Prev Close
$0.8251
Open
$0.627
50D MA
$3.40
Beta
0.53
Avg. Volume
650,737.42
EPS (Annual)
-$6.98
P/B
-0.09
Rev/Employee
$52,000.00
Loading...
Loading...
Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
32

Frequently Asked Questions

What is Market Cap of Clearside Biomedical Inc?
What is the 52-week high for Clearside Biomedical Inc?
What is the 52-week low for Clearside Biomedical Inc?
What is Clearside Biomedical Inc stock price today?
What was Clearside Biomedical Inc stock price yesterday?
What is the PE ratio of Clearside Biomedical Inc?
What is the Price-to-Book ratio of Clearside Biomedical Inc?
What is the 50-day moving average of Clearside Biomedical Inc?
How many employess does Clearside Biomedical Inc has?

Latest CLSD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.